Hong Kong Science and Technology Commission: China Kexing vaccine has limited effect and the highest side effects

Hong Kong is about to enter the era of vaccination against the new coronavirus, Hong Kong people from the day after tomorrow can make an appointment Friday (26) to start the vaccination (Bureau called shots) program, the first supply of vaccines manufactured by China Kexing, but the tentative proposed consensus of the Hong Kong Government’s Joint Scientific Committee that vaccination Kexing vaccine on the limited evidence of effective prevention of the spread of the virus, coupled with restrictions on the supply of vaccines, the “population protection has not been achieved in the short term.” However, the Hong Kong government’s top officials for four days out to call on the public to vaccinate, “the sooner the better,” and that the public can download electronic needle cards after vaccination, to provide the basis for future clearance.

The Hong Kong government’s Joint Scientific Committee yesterday (20) early in the morning on the use of Kexing vaccine in Hong Kong published a tentative consensus proposal document more pointed out that if the vaccine supply delays, or vaccination rate is insufficient, more will extend non-drug intervention measures, such as social distance measures. Professor Xu Shuchang, a member of the Scientific Committee, expects that by the end of this year, more than 70% of the public will have received the vaccine and produced antibodies, so that the community will have a group protection effect, and the preventive measures can be relaxed at that Time. Earlier polls conducted by different academic and pharmacist groups in Hong Kong showed that the proportion of citizens willing to receive the vaccine ranged from more than 30% to 40%, far below the 70% vaccination rate needed to achieve herd immunity.

According to the data submitted to the Scientific Committee by Kexing, the overall effectiveness of the vaccine is 50.66%, and if the second dose is administered 28 days apart, its effectiveness can rise to 62.3%, but it is still lower than the Pfizer BioNTech vaccine, which was approved earlier but has not yet arrived in Hong Kong, the overall effectiveness of the latter is 95%, however, its side effects are the greater among the three vaccines. To encourage the public to vaccinate, Chief Secretary for Administration Matthew Cheung Kin-chung wrote an article in the social networking blog this morning (21), saying that he would use different channels to clear the public’s doubts about the vaccine and to dispel rumors of false information in the community in real time.

The main responsibility for the fight against the Epidemic of the Secretary for Food and health Chan Siu-chee this morning attended a radio program appeal, that the global daily number of new confirmed cases recently seems to have fallen back to the trend, many experts believe that the vaccination is related to the public vaccination, so that the community as soon as possible to have mass immunization, in order to resume normal Life as soon as possible, to provide more favorable conditions for customs clearance. Faced with the wait-and-see attitude of the public, she said that vaccination must be better than no vaccination for the sake of individuals and society, and that “it is better to get (the shot) early than to get (it) late.”

Even the Secretary for Civil Service Affairs Nie Dequan also appeared on the radio program yesterday to call on the public to vaccinate, that the public after the injection from the “smart convenience” of the government platform to download the electronic version of the needle card, not only can record the public vaccination data, the platform at the same time to store virus detection records, etc., to provide the basis for future cross-border travel. But when asked when the customs clearance with China, he said it would be “very soon”, but also said, still have to wait for the stability of the epidemic in Hong Kong, the number of confirmed units per day, or even “zero”, before there is a basis for discussion.

The public’s reaction is the opposite of expert advice

In addition, according to the tentative consensus of the Scientific Committee, the scientific evidence of the application of the Kexing vaccine in the elderly is less, it is necessary to pay attention to its effectiveness, and to pay attention to the impact of variant strains of the virus on the effectiveness of the vaccine and rare clinical side effects. Professor Hsu Shu-cheong said on a radio program yesterday morning that elderly people in poor health should not be vaccinated, citing the example of aspiration pneumonia if the vaccine causes vomiting and the patient has had a stroke and has swallowing problems.

But the reality is that, according to a Family doctor, of the more than 50 people who called the clinic to express their interest in making an appointment, the older and chronically ill preferred to get the Coxin, mainly because they were more confident in using the traditional inactivation technique, while the younger people preferred to get BioNTech.